INSMED Inc. Files 8-K with Regulatory Disclosures
Ticker: INSM · Form: 8-K · Filed: 2026-04-07T16:01:21-04:00
Sentiment: neutral
Topics: 8-K, regulatory-disclosure, filing
Related Tickers: INSM
TL;DR
INSMED filed an 8-K on 4/7/26 with various disclosures and exhibits.
AI Summary
On April 7, 2026, INSMED Inc. filed an 8-K report detailing events under Regulation FD Disclosure, Other Events, and Financial Statements/Exhibits. The filing includes an iXBRL 8-K document and exhibits such as EX-99.1, a graphic image, and XBRL data files.
Why It Matters
This 8-K filing provides important updates and disclosures from INSMED Inc. to the public, ensuring transparency and compliance with SEC regulations.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report and does not appear to contain any immediately alarming or significant negative news.
Key Numbers
- 39440 — 8-K iXBRL Size (Size of the main 8-K filing in bytes.)
- 20387 — EX-99.1 Size (Size of Exhibit 99.1 in bytes.)
Key Players & Entities
- INSMED Inc. (company) — Filer of the 8-K report
- 0001104506 (company) — CIK number for INSMED Inc.
- 2026-04-07 (date) — Filing date and period of report
FAQ
What specific items are covered in this 8-K filing by INSMED Inc.?
This 8-K filing covers Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits).
When was this 8-K report filed and accepted by the SEC?
The 8-K report was filed and accepted by the SEC on April 7, 2026.
What is the CIK number for INSMED Inc.?
The CIK number for INSMED Inc. is 0001104506.
What is the business address of INSMED Inc.?
The business address of INSMED Inc. is 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807.
What types of XBRL files are included in this filing?
This filing includes XBRL taxonomy extension schema, label linkbase, and presentation linkbase files, along with an extracted XBRL instance document.
From the Filing
EDGAR Filing Documents for 0001140361-26-013659 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001140361-26-013659 Filing Date 2026-04-07 Accepted 2026-04-07 16:01:21 Documents 13 Period of Report 2026-04-07 Items Item 7.01: Regulation FD Disclosure Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits Interactive Data Document Format Files Seq Description Document Type Size 1 8-K ef20070042_8k.htm iXBRL 8-K 39440 2 EXHIBIT 99.1 ef20070042_ex99-1.htm EX-99.1 20387 6 image00001.jpg GRAPHIC 2092 Complete submission text file 0001140361-26-013659.txt 197493 Data Files Seq Description Document Type Size 3 XBRL TAXONOMY EXTENSION SCHEMA insm-20260407.xsd EX-101.SCH 3859 4 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20260407_lab.xml EX-101.LAB 21966 5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20260407_pre.xml EX-101.PRE 16040 16 EXTRACTED XBRL INSTANCE DOCUMENT ef20070042_8k_htm.xml XML 4065 Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900 INSMED Inc (Filer) CIK : 0001104506 (see all company filings) EIN. : 541972729 | State of Incorp.: VA | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 26844667 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)